{
    "organizations": [],
    "uuid": "2895fc66605caa759611105236f52cf1b9788431",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-eyegate-receives-fda-feedback-on-i/brief-eyegate-receives-fda-feedback-on-investigational-device-exemption-amendment-for-second-pilot-study-of-ocular-bandage-gel-idUSFWN1RM0L7",
    "ord_in_thread": 0,
    "title": "BRIEF-Eyegate Receives FDA Feedback On Investigational Device Exemption Amendment For Second Pilot Study Of Ocular Bandage Gel",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 9 (Reuters) - EyeGate Pharmaceuticals Inc:\n* EYEGATE RECEIVES FDA FEEDBACK ON INVESTIGATIONAL DEVICE EXEMPTION AMENDMENT FOR SECOND PILOT STUDY OF OCULAR BANDAGE GEL\n* IN ITS LETTER, FDA IDENTIFIED FOUR DEFICIENCIES IN COMPANY’S SUBMISSION\n* FDA REQUESTED ADDITIONAL INFORMATION ON MANUFACTURING PROCESSES ASSOCIATED WITH EYEGATE OBG PRODUCT\n* CO TARGETING SUBMISSION OF A SECOND AMENDMENT TO IDE APPLICATION IN JULY 2018\n* IN U.S. FDA’S LETTER, PRIMARY COMMENT RELATES TO VALIDATION OF FILTER SPECIFICALLY USED FOR STERILIZATION OF CMHA MATERIAL Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-04-09T21:11:00.000+03:00",
    "crawled": "2018-04-10T12:43:16.026+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "eyegate",
        "pharmaceutical",
        "inc",
        "eyegate",
        "receives",
        "fda",
        "feedback",
        "investigational",
        "device",
        "exemption",
        "amendment",
        "second",
        "pilot",
        "study",
        "ocular",
        "bandage",
        "gel",
        "letter",
        "fda",
        "identified",
        "four",
        "deficiency",
        "company",
        "submission",
        "fda",
        "requested",
        "additional",
        "information",
        "manufacturing",
        "process",
        "associated",
        "eyegate",
        "obg",
        "product",
        "co",
        "targeting",
        "submission",
        "second",
        "amendment",
        "ide",
        "application",
        "july",
        "fda",
        "letter",
        "primary",
        "comment",
        "relates",
        "validation",
        "filter",
        "specifically",
        "used",
        "sterilization",
        "cmha",
        "material",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}